162 related articles for article (PubMed ID: 37253623)
1. Genetic Considerations in the Tumorigenesis, Diagnosis, and Treatment of Differentiated Thyroid Cancer: Current State of the Science.
Richmond BK; Gallimore J
Am Surg; 2023 Nov; 89(11):4853-4859. PubMed ID: 37253623
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy.
Liu R; Xing M
Endocr Relat Cancer; 2014 Oct; 21(5):825-30. PubMed ID: 25121551
[TBL] [Abstract][Full Text] [Related]
3. ROLE OF MOLECULAR MARKERS IN THYROID NODULE MANAGEMENT: THEN AND NOW.
Nikiforov YE
Endocr Pract; 2017 Aug; 23(8):979-988. PubMed ID: 28534687
[TBL] [Abstract][Full Text] [Related]
4. [Molecular Pathogenesis of Thyroid Nodules: Relevance for Clinical Care].
Führer D; Musholt T; Schmid KW
Laryngorhinootologie; 2017 Sep; 96(9):590-596. PubMed ID: 28881369
[TBL] [Abstract][Full Text] [Related]
5. How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid-based cytology: Role of TERT promoter and BRAF V600E mutation analysis.
Dell'Aquila M; Fiorentino V; Martini M; Capodimonti S; Cenci T; Lombardi CP; Raffaelli M; Pontecorvi A; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
Cancer Cytopathol; 2021 Oct; 129(10):819-829. PubMed ID: 34076961
[TBL] [Abstract][Full Text] [Related]
6. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
[TBL] [Abstract][Full Text] [Related]
7. A five-gene panel refines differential diagnosis of thyroid nodules.
Lu SY; Chen YC; Zhu CF; Chen J; Zhou QY; Zhang MM; Zhang QY; Lu M; Yang L; Wu J; Zhao SX; Song HD; Ye XP
J Clin Lab Anal; 2021 Sep; 35(9):e23920. PubMed ID: 34318534
[TBL] [Abstract][Full Text] [Related]
8. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
[TBL] [Abstract][Full Text] [Related]
9. Thyroid cancer: the impact of emerging technologies on clinical practice guidelines.
Mechanick JI; Carpi A
Biomed Pharmacother; 2008 Oct; 62(8):554-8. PubMed ID: 18752920
[TBL] [Abstract][Full Text] [Related]
10. [Genetics of thyroid nodules and thyroid carcinoma].
Führer D
Internist (Berl); 2018 Jul; 59(7):674-680. PubMed ID: 29931438
[TBL] [Abstract][Full Text] [Related]
11. PREDICTIVE VALUE OF SOMATIC MUTATIONS FOR THE DEVELOPMENT OF MALIGNANCY IN THYROID NODULES BY CYTOPATHOLOGY.
Halászlaki C; Tóbiás B; Balla B; Kósa JP; Horányi J; Bölöny E; Nagy Z; Speer G; Járay B; Székely E; Istók R; Székely T; Putz Z; Dank M; Lakatos P; Takács I
Endocr Pract; 2016 Sep; 22(9):1081-7. PubMed ID: 27214302
[TBL] [Abstract][Full Text] [Related]
12. The role of fine-needle aspiration biopsy in the management of palpable thyroid nodules.
Greenspan FS
Am J Clin Pathol; 1997 Oct; 108(4 Suppl 1):S26-30. PubMed ID: 9322610
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of a thyroid nodule].
Tryggvason G; Briem B
Laeknabladid; 2017 Januar; 102(1):23-27. PubMed ID: 28497767
[TBL] [Abstract][Full Text] [Related]
14. [Preoperative molecular testing on fine-needle aspiration in precision management of thyroid cancer].
Song YT; Zhang B
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):58-61. PubMed ID: 30704174
[TBL] [Abstract][Full Text] [Related]
15. Current Diagnosis and Management of Thyroid Nodules.
Pemayun TG
Acta Med Indones; 2016 Jul; 48(3):247-257. PubMed ID: 27840362
[TBL] [Abstract][Full Text] [Related]
16. Update on Fundamental Mechanisms of Thyroid Cancer.
Prete A; Borges de Souza P; Censi S; Muzza M; Nucci N; Sponziello M
Front Endocrinol (Lausanne); 2020; 11():102. PubMed ID: 32231639
[TBL] [Abstract][Full Text] [Related]
17. Overview of the 2015 American Thyroid Association guidelines for managing thyroid nodules and differentiated thyroid cancer.
Matti B; Cohen-Hallaleh R
N Z Med J; 2016 Sep; 129(1441):78-86. PubMed ID: 27607088
[TBL] [Abstract][Full Text] [Related]
18. Clinical Utility of BRAF, NRAS, and TERT Promoter Mutation in Preoperative Thyroid Fine-Needle Aspiration Biopsy: A Diagnostic Study From Dharmais Cancer Hospital.
Perdana AB; Putri RI; Rachmawati R; Andinata B; Brahma B
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3267-3277. PubMed ID: 33247684
[TBL] [Abstract][Full Text] [Related]
19. Fine-needle biopsy of thyroid nodules and the contribution of molecular analysis of BRAF and RAS mutations.
Kasko M; Grigerova M; Alemayehu A; Zavodna K; Kasko V; Podoba J
Bratisl Lek Listy; 2023; 124(12):869-872. PubMed ID: 37983279
[TBL] [Abstract][Full Text] [Related]
20. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
Rossi M; Buratto M; Bruni S; Filieri C; Tagliati F; Trasforini G; Rossi R; Beccati MD; Degli Uberti EC; Zatelli MC
J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
